D-Dopa,
5796-17-8,
(R)-2-Amino-3-(3,4-dihydroxyphenyl)propanoic acid,
Dopa D-form,
3-Hydroxy-D-tyrosine,
3,4-Dihydroxy-D-phenylalanine,
D-3,4-Dihydroxyphenylalanine,
(+)-3,4-Dihydroxyphenylalanine,
(+)-3-(3,4-Dihydroxyphenyl)alanine,
UNII-8T862R29FY,
D-3-Hydroxytyrosine,
D-Tyrosine, 3-hydroxy-,
CHEBI:49169,
D-3-(3,4-Dihydroxyphenyl)alanine,
8T862R29FY,
3-(3,4-Dihydroxyphenyl)-D-alanine,
(2R)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid,
Dopa,
C9H11NO4,
EINECS 227-343-0,
NSC 118368,
3- hydroxy D- Tyrosine,
AC1L3NO7,
3,4-Dihydroxy-D-phenylaline,
SCHEMBL342665,
3,4-Dihydroxy-D-phenylanline,
CHEMBL211670,
CTK1H2134,
DTXSID70206673,
D-Tyrosine, 3-hydroxy- (9CI),
ZINC1506908,
ANW-63265,
MFCD00063061,
AKOS016843249,
FCH1158724,
NCGC00016270-02,
NCGC00016270-03,
NCGC00016270-05,
NCGC00093869-01,
NCGC00093869-02,
NCGC00093869-03,
AJ-26439,
AK-87825,
O103,
SC-70884,
AX8034158,
TC-152010,
FT-0082298,
FT-0650636,
3,4-Dihydroxy-D-phenylalanine, powder, >=95%,
Alanine, 3-(3,4-dihydroxyphenyl)-, D- (8CI),
C-47157,
UNII-QI9C343R60 component WTDRDQBEARUVNC-ZCFIWIBFSA-N,
levodopa,
Dopa, D-,
Levodopa EP Impurity D,
D-B-3,4-Dihydroxyphenylalanine,
C9-H11-N-O4,
CID92222,
CS-O-10846,
Alanine, 3-(3,4-dihydroxyphenyl)-, D-,
(R)-2-Amino-3-(3,4-dihydroxyphenyl)propanoicacid,